Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2003
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/06/2003WO2003091443A1 Synthetic transfer complex and method for transferring nucleic acids
11/06/2003WO2003091429A1 Antimicrobial polypeptide and utizliation thereof
11/06/2003WO2003091395A2 Inhibition of immune complex formation
11/06/2003WO2003090719A1 Histidine copolymer and methods for using same
11/06/2003WO2003090697A2 Chimeric hybrid analgesics
11/06/2003WO2003054009A3 Apoptotically active peptides
11/06/2003WO2003046570A3 Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
11/06/2003WO2003033011A3 Repetitive motifs from salivary proline rich proteins, mucin and collagen
11/06/2003WO2003032901A3 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/06/2003WO2003007686A3 Use of copper chelators to inhibit the inactivation of protein c
11/06/2003WO2002094845A3 Method for stabilising of nucleic acids
11/06/2003WO2002066984A8 Arrays for determining binding of biomolecules
11/06/2003WO2002060491A3 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
11/06/2003WO2002059352A3 Methods and means for detecting enzymatic cleavage and linkage reactions
11/06/2003WO2002024883A3 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003US20030208059 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030208037 Novel fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207804 Peptide nucleic acids exhibit enhanced cellular uptake and distribution. The peptide nucleic acids of the invention comprise naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide
11/06/2003US20030207798 Hair growth promoting agent including a cyclosporin derivative as an active ingredient, and more particularly, a hair growth promoting agent including a cyclosporin A derivative substituted in the 3-position as an active ingredient.
11/06/2003US20030207400 Double stranded DNA of target sequence(s) bound non-covalently to a sequence specific polyamide (SSP) moiety having a ligand moiety linked covalently to said polyamide; polyamide contains N-methylpyrrole or N-methylimidazole groups
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030207324 Immunotherapy by modulation of antigen presentation
11/06/2003US20030207264 Use of a single fluorophore rather than an "acceptor-donor" fluoresecence resonance energy transfer system offers synthesis and performance advantages; fluorogenic protease indicators
11/06/2003CA2478680A1 Chimeric hybrid analgesics
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1357934A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP0777679B1 Delivery of nucleic acids
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454214A Modified peptides with increased potency
11/05/2003CN1454082A Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
11/05/2003CN1453291A Synthesis and use of organic polypeptide compound
11/05/2003CN1126759C Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone
11/04/2003US6642371 Haemophilus adherence and penetration proteins
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642357 Process for preparing modified proteins
11/04/2003US6642356 Of given amino acid sequence; non-immunogenic; Fab fragment coupled to effector or reporter molecules; generates dimers which are resistant to chemical reduction
11/04/2003US6642355 Endothelin-antagonizing peptide
11/04/2003US6642354 Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
11/04/2003US6641820 Treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to target
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003CA2084677C Apo ai polypeptides, antibodies, and immunoassays
10/2003
10/30/2003WO2003089922A1 Method for detecting ligands and targets in a mixture
10/30/2003WO2003089663A2 Methods for measuring enzyme activity
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089607A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003WO2003089590A2 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH
10/30/2003WO2003089458A2 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003WO2003089457A2 Peptide inhibitors of protein kinase c ϝ for pain management
10/30/2003WO2003089456A2 Peptide inhibitors of protein kinase c
10/30/2003WO2003088990A1 Plasma protein-binding ligands
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002070547A8 Template-fixed peptidomimetics with antimicrobial activity
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204063 Growth hormone releasing factor; somatostatins; glucagon-like peptides; adrenocorticotropic hormones; atriopeptins; vasoactive intestinal peptides; for glucose intolerance associated with insulin resistance
10/30/2003US20030204050 Comprises polypeptide for treating arthritis, cancer, autoimmune, kidney and inflammatory disorders
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203849 Composition promoting lacrimal secretion
10/30/2003US20030203848 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203834 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
10/30/2003US20030203415 Comprises polypeptide for, diagnosis, detection and treatment of cancer
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030202981 Chimeric hybrid analgesics
10/30/2003CA2785889A1 Peptide inhibitors of protein kinase c
10/30/2003CA2482856A1 Plasma protein-binding ligands
10/30/2003CA2482764A1 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them
10/30/2003CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003CA2482529A1 Method for detecting ligands and targets in a mixture
10/30/2003CA2481512A1 Peptide inhibitors of protein kinase c.gamma. for pain management
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/29/2003EP1356279A2 Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-throughput screening assays
10/29/2003EP1356084A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
10/29/2003EP1355965A2 Block copolymers for multifunctional self-assembled systems
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355920A1 Extractive purification of lipopeptide antibiotics
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1105404B1 Purification of oligomers using dual-end selection
10/29/2003EP1019528B1 Method for assaying proteolytic enzymes using fluorescence-quenched substrates
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452632A Extended native chemical ligation
10/29/2003CN1452492A Neuroprotective peptides
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 423